Organisation paid for research Program year 2025 Source: CMS Open Payments

Patient Priority CLNC Sites

Neither a doctor nor a teaching hospital

Research payments

$576,904

51 payments

Through program year 2025, Patient Priority CLNC Sites is reported as receiving $576,904 in research payments, across 51 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$30,719	5
2024	Research	$252,100	19
2023	Research	$246,724	24
2022	Research	$47,361	3

Breakdown

Who paid Research payments · program years 2022–2025

Janssen Research & Development, LLC $576,904 51 payments

Studies the money was for Research payments · program years 2022–2025

67953964Mdd3003 $325,802 25 payments
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate to Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. $231,125 23 payments
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT) $19,977 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.